Bioequivalence: Issues and options

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 25, Issue 6, 1997, Pages 743-752

  Midha, Kamal K ^a   Rawsom, Maureen J ^a   Hubbard, John W ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

BIOEQUIVALENCE; DECISION MAKING; DRUG FORMULATION; FOOD AND DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; STEREOISOMERISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DOXEPIN; HUMANS; KETOPROFEN; NORTRIPTYLINE; STEREOISOMERISM; THERAPEUTIC EQUIVALENCY;

EID: 0031397620     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. L. Z. Benet and J. E. Goyan. Bioequivalence and narrow therapeutic index drugs. Pharmacotherapy 15:433-40 (1995).
2. V. Shah, A. Yacobi, W. Barr, D. Breimer, M. Dobrinska, E. Endrenyi, W. Fairweather, W. Gillespie, M. Gonzales, J. Hooper, L. Lesko, K. Midha, P. Noonan, R. Patnaik, and R. Williams. Evaluation of orally administered highly variable drugs and drug formulations. Pharm. Res. 13:1590-1594 (1996).
3. E. Ariens and E. Wuis. Bias in pharmacokinetics and clinical pharmacology. Clin. Pharmacol. Ther. 42:361-363 (1987).
4. H. H. Blume and K. K. Midha. Bio International '92, Conference on Bioavailability, Bioequivalence and Pharmacokinetic Studies. J. Pharm. Sci. 82:1186-1189 (1993).
5. S. Qureshi, G. Caille, Y. Lacasse, and I. McGilveray. Pharmacokinetics of two enteric-coated ketoprofen products in humans with or without coadministration of omeprazole and comparison with solution finding. Pharm. Res. 11:1669-1672 (1994).
6. Y.-H. Yan, J. Hubbard, G. McKay, and K. Midha. Stereoselective in vivo and in vitro studies on the metabolism of doxepin and n-desmethyldoxepin. Xenobiotica (in press) (1997).
7. K. K. Midha, J. W. Hubbard, M. Rawson, and R. Schwede. The impact of stereoisomerism in a bioequivalence study on two formulations of doxepin. Eur. J. Pharm. Sci. 4:133-138 (1996).
8. K. K. Midha, J. W. Hubbard, G. McKay, M. Rawson, and R. Schwede. Stereoselectivity in bioequivalence studies of nortriptyline. J. Pharma. Sci. 84:1265-1266 (1995).
9. H. H. Blume, I. J. McGilveray, and K. K. Midha. Bio International '94, Conference on bioavailability, bioequivalence and pharmacokinetics studies - pre-conference satellite on in vivo/in vitro correlation. Eur. J. Pharm. Sci. 3:113-124 (1995).
10. K. K. Midha, J. W. Hubbard, P. K.-F. Yeung, E. Ormsby, G. McKay, E. M. Hawes, E. D. Korchinski, T. Gurnsey, M. J. Rawson, and R. Schwede. In K. K. Midha and H. H. Blume (eds.), Bio-International: Bioavailability, Bioequivalence and Pharmacokinetics; International Conference of F.I.P. "Bio- International '92" Medpharm Scientific Publishers, Stuttgart, 1993, pp. 53-68.
11. D. R. Brocks, K. J. Skeith, C. Johnston, J. Emamibafrani, P. Davis, A. S. Russell, and F. Jamali. Hematologic disposition of hydroxychloroquine enantiomers. J. Clin. Pharmacol. 34:1088-1097 (1994).
12. K. Midha, J. Hubbard, M. Rawson, G. McKay, and R. Schwede. The role of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: A drug with a very long half life. Eur. J. Pharm. Sci. 4:283-292 (1996).
13. K. K. Midha, J. W. Hubbard, M. J. Rawson, and L. Gavalas. The application of partial areas in assessment of rate and extent of absorption in bioequivalence studies of conventional release products: Experimental evidence. Eur. J. Pharm. Sci. 2:351-363 (1994).
14. N. R. Srinivas, W. H. Barr, W. C. Shyu, E. Mohandoss, S. Chow, J. Staggers, G. Balan, F. J. Belas, I. A. Blair, and R. H. Barbhaiya. Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: Assessment using stereospecific and non-stereospecific assays. J. Pharm. Sci. 85:299-303 (1996).
15. A. Karim. Enantioselective assays in comparative bioavailability studies of racemic drug formulations: Nice to know or need to know? J. Clin. Pharmacol. 36:490-499 (1996).